Currently, tirzepatide demonstrates superior outcomes compared to semaglutide in real-world practice, with 12-month weight reductions of 15.3% versus 8.3% respectively
When your provider can no longer source reliable compounded tirzepatide, switching to semaglutide may be your only option for continuing GLP-1 therapy
You are a warrior, and you DID NOT fail if you had a C-section
The B12 wont become toxic, but it will gradually lose potency
Common sites include the deltoid, vastus lateralis, and gluteal muscles
1 Introduction Several risk factors are shared between type 2 diabetes (T2D) and cardiovascular disease (CVD), obesity, dyslipidaemia, insulin resistance, and hyperglycaemia